Shigetaka Suekane

Induction of cellular and humoral immune responses to tumor cells and peptides in HLA‐A24 positive hormone‐refractory prostate cancer patients by peptide vaccination

Masanori Noguchi, Kazuhiko Kobayashi, Norie Suetsugu et al. · The Prostate · 2003 · 104 citations

Medicine, Immunology, Oncology +17

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer

Masanori Noguchi, Tatsuyuki Kakuma, Hirotsugu Uemura et al. · Cancer Immunology Immunotherapy · 2010 · 102 citations · Full text

Medicine, Immunology, Oncology +16

Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line

Kosuke Ueda, Sachiko Ogasawara, Jun Akiba et al. · PLoS ONE · 2013 · 91 citations · Full text

Medicine, Cell Biology, Oncology +13

Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma

Kousuke Ueda, Shigetaka Suekane, Hirofumi Kurose et al. · Urologic Oncology Seminars and Original Investigations · 2018 · 79 citations · Full text

Medicine, Immunology, Oncology +17

An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy

Masanori Noguchi, Kazumasa Matsumoto, Hirotsugu Uemura et al. · Clinical Cancer Research · 2015 · 59 citations

Medicine, Oncology, Pharmacology +17